Dahan Michel

SVP, Chief Operating Officer | SVP, Chief Business Officer

1 company

Good

Trades Analyzed

12M Win Rate

50.0%

Avg 3M Return

+19.6%

Avg 12M Return

-4.8%

Dahan Michel is a SVP, Chief Operating Officer at Akebia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $780K based on current market prices.

Holdings by Company

AKBAMay 13, 2024

Current Shares672.1K

Value$779.6K

Net Activity-244,519

Bought: 0Sold: 244.5K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 13, 2024	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	34,840	$1.26	$43,898.40	-4.9%	-4.7%	+92.2%
Feb 29, 2024	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	8,661	$1.58	$13,684.38	-1.2%	-34.8%	+17.1%
Feb 27, 2024	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	10,744	$1.52	$16,330.88	-1.5%	-34.8%	+9.8%
May 25, 2023	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	95,478	$1.22	$116,760.05	-14.3%	+6.6%	-9.1%
Mar 1, 2023	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	20,412	$0.88	$17,911.53	-2.4%	+4.8%	+72.7%
Feb 27, 2023	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	10,090	$0.81	$8,205.19	-3.4%	+17.5%	+101.1%
Mar 1, 2022	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	21,533	$2.17	$46,637.46	-1.8%	-82.8%	-57.4%
Apr 1, 2021	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	1,211	$3.40	$4,117.40	-0.5%	+13.8%	-79.9%
Mar 1, 2021	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	14,547	$3.40	$49,403.07	-2.7%	+1.3%	-36.1%
Feb 28, 2020	AKBA Akebia Therapeutics, Inc.	SVP, Chief Operating Officer	Sell	6,972	$8.70	$60,656.40	-3.3%	-	-